Annual Revenue
N/A
December 31, 2023
Summary
- APVO annual revenue is not available.
Performance
APVO Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2024
Summary
- APVO quarterly revenue is not available.
Performance
APVO Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2024
Summary
- APVO TTM revenue is not available.
Performance
APVO TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
APVO Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
APVO Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Aptevo Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $3.11 M(-74.7%) | - | - |
| Mar 2022 | - | $3.11 M(-15.0%) | $12.98 M(+5.6%) |
| Dec 2021 | $12.29 M(+185.3%) | $3.67 M(+18.4%) | $12.29 M(+11.7%) |
| Sep 2021 | - | $3.10 M(-0.5%) | $11.00 M(+17.4%) |
| Jun 2021 | - | $3.11 M(+28.5%) | $9.37 M(+39.2%) |
| Mar 2021 | - | $2.42 M(+2.0%) | $6.73 M(+56.2%) |
| Dec 2020 | $4.31 M(-81.3%) | $2.37 M(+62.2%) | $4.31 M(+122.6%) |
| Sep 2020 | - | $1.46 M(+209.3%) | $1.94 M(+309.3%) |
| Jun 2020 | - | $473.00 K(-92.5%) | $473.00 K(-97.9%) |
| Dec 2018 | $23.07 M(+57.4%) | $6.35 M(+9.0%) | $23.07 M(+18.1%) |
| Sep 2018 | - | $5.82 M(-14.7%) | $19.54 M(-1.7%) |
| Jun 2018 | - | $6.83 M(+67.7%) | $19.89 M(+19.9%) |
| Mar 2018 | - | $4.07 M(+44.5%) | $16.59 M(+13.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $14.66 M(+46.8%) | $2.82 M(-54.3%) | $14.66 M(+0.2%) |
| Sep 2017 | - | $6.17 M(+75.0%) | $14.62 M(+29.8%) |
| Jun 2017 | - | $3.53 M(+64.6%) | $11.27 M(-37.2%) |
| Mar 2017 | - | $2.14 M(-23.0%) | $17.93 M(-24.8%) |
| Dec 2016 | $9.98 M(-70.3%) | $2.78 M(-1.2%) | $23.86 M(-18.7%) |
| Sep 2016 | - | $2.82 M(-72.4%) | $29.36 M(-11.3%) |
| Jun 2016 | - | $10.19 M(+26.4%) | $33.11 M(+10.3%) |
| Mar 2016 | - | $8.07 M(-2.6%) | $30.00 M(-10.7%) |
| Dec 2015 | $33.60 M(-26.4%) | $8.29 M(+26.3%) | $33.60 M(+32.7%) |
| Sep 2015 | - | $6.56 M(-7.4%) | $25.32 M(+35.0%) |
| Jun 2015 | - | $7.09 M(-39.2%) | $18.75 M(+60.8%) |
| Mar 2015 | - | $11.66 M | $11.66 M |
| Dec 2014 | $45.63 M(>+9900.0%) | - | - |
| Dec 2013 | $170.00 K | - | - |
FAQ
- What is the all time high annual revenue for Aptevo Therapeutics?
- What is the all time high quarterly revenue for Aptevo Therapeutics?
- What is the all time high TTM revenue for Aptevo Therapeutics?
What is the all time high annual revenue for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual revenue is $45.63 M
What is the all time high quarterly revenue for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly revenue is $11.66 M
What is the all time high TTM revenue for Aptevo Therapeutics?
Aptevo Therapeutics all-time high TTM revenue is $33.60 M